Analysis of NAT2 point mutations with biological microchips

[1]  A. Zasedatelev,et al.  [Analysis of point mutations in BRCA1 gene using hybridization on hydrogel microchips]. , 2006, Molekuliarnaia biologiia.

[2]  A. Zasedatelev,et al.  Analysis of point mutations of the BRCA1 gene by hybridization with hydrogel microarrays , 2006, Molecular Biology.

[3]  V. Baranov,et al.  [Biochip development for polymorphism analysis in biotransformation system genes]. , 2005, Molekuliarnaia biologiia.

[4]  V. Baranov,et al.  Development of a Biochip for Analyzing Polymorphism of the Biotransformation Genes , 2005, Molecular Biology.

[5]  Dong Liang,et al.  Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. , 2005, Mutation research.

[6]  R. Hayes,et al.  Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  D. Zaletaev,et al.  The Association of NAT2 Polymorphisms with Sporadic Breast Cancer , 2004, Molecular Biology.

[8]  D. Hein.  Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. , 2002, Mutation research.

[9]  Manal M. Hassan,et al.  Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. , 2002, Carcinogenesis.

[10]  G. Jakse,et al.  Epidemiology and biology of human urinary bladder cancer , 2000, Journal of Cancer Research and Clinical Oncology.

[11]  B. Dallapiccola,et al.  Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. , 1999, The Journal of investigative dermatology.

[12]  T. Henseler,et al.  Genetics of psoriasis , 1998, Archives of Dermatological Research.

[13]  E. Schnakenberg,et al.  Genotyping of the polymorphic N‐acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients , 1998, Clinical genetics.

[14]  A. Mirzabekov,et al.  Parallel thermodynamic analysis of duplexes on oligodeoxyribonucleotide microchips. , 1998, Nucleic acids research.

[15]  G. Fakis,et al.  Expression of arylamine N-acetyltransferase in human intestine , 1998, Gut.

[16]  C. Davis,et al.  N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. , 1996, Cancer research.

[17]  D. Grant,et al.  Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations. , 1996, Pharmacogenetics.

[18]  A. Risch,et al.  Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. , 1995, Human molecular genetics.

[19]  M. Butler,et al.  Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. , 1991, Carcinogenesis.

[20]  W. Weber,et al.  Diverse point mutations in the human gene for polymorphic N-acetyltransferase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Johns,et al.  Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. , 1989, Analytical biochemistry.

[22]  R. S. Rogers.  Genetics of psoriasis. , 1975, Minnesota medicine.

[23]  J. W. Jennne.  Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. , 1965, The Journal of clinical investigation.